Cerebrovascular Disorders During COVID-19 Pandemic: What Should We Know

Ghaydaa Shehata, A.

Consultant Neurologist, Professor of Neurology, Department of Neurology and Psychiatry, Assuit University Hospitals, Assuit, Egypt

Dr. Ghaydaa Shehata, A., Consultant Neurologist, Professor of Neurology, Department of Neurology and Psychiatry, Assuit University Hospitals, Assuit, Egypt.

Keywords: COVID-19; Neurology; Stroke; Cerebrovascular Disorders; Anticoagulants

Abstract

A New detected a virus called COVID-19 reported by World Health Organization (WHO) as pandemic at March 2020 COVID-19 is affected mainly by respiratory illness, but it can also affect the brain. Cerebrovascular disorders are recorded COVID-19 pandemics but are not effectively addressed how to deal and treat them. In this review, I try to discuss the postulated neuronal mechanisms of the coronavirus infection sequelae. After made midlines about this topic and collected more international papers. I discuss prevalence, pathogenesis, and then put a proposal on how to deal with Cerebrovascular disorders with COVID-19. Also, I discuss the protocol algorithm for anticoagulants in the COVID-19 era.
The aim of this review is to educate and update the neurologists and health team who working with suspected cases of COVID-19 with Cerebrovascular disorders.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).